Navigation Links
Media advisory: Brain cell injections may quiet epileptic seizures
Date:5/5/2013

More than two million people in the United States suffer from epilepsies, a group of neurological disorders caused by abnormal nerve cell firing in the brain which often produce debilitating seizures. Although anti-epileptic drugs and other therapies reduce seizures in about two-thirds of patients, the remaining one-third do not respond to any form of therapy and those who take drugs can experience harmful side effects. NIH funded researchers at the University of California at San Francisco used a mouse model of epilepsy to show that transplanting new born inhibitory nerve cells can quiet seizures. Inhibitory cells are one of two major nerve cell groups, the other being excitatory. Their results, published in Nature Neuroscience, show that injecting new inhibitory cells into the hippocampus in the brains of adult epileptic mice greatly reduced the occurrence of seizures and reversed some learning and memory problems associated with the disorder. Analysis of the mice brains suggested the new cells became fully incorporated into the brain regions where they were injected. The results support the idea that cell therapies may provide precise and novel ways to treat epilepsy and other neurological disorders.


'/>"/>

Contact: Christopher Thomas
nindspressteam@ninds.nih.gov
301-496-5751
NIH/National Institute of Neurological Disorders and Stroke
Source:Eurekalert

Page: 1

Related biology news :

1. G protein-coupled receptor mediates the action of castor oil
2. NineSigma Launches NineSights, the Worlds First Open Innovation Social Media Destination for Innovation Seekers and Solution Providers
3. Media registration opens for Neuroscience 2012, worlds largest brain science meeting
4. Evermedia Group Announces 375% Increase in Revenue for Second Quarter 2012
5. Medbox, Inc. Releases Demo Video and Collateral Media Concerning How Their Systems Will Be Used in Massachusetts Medical Marijuana Dispensaries
6. Outside a vacuum: Model predicts movement of charged particles in complex media
7. Medbox, Inc. Featured in Multiple Media Stories in Massachusetts and California
8. BodyMedia & FitOrbit Up the Ante in Personalized Weight Loss
9. New report finds increase in media coverage of synthetic biology
10. Media invited: Biophysical Society Annual Meeting
11. Monitoring and robust induction of nephrogenic intermediate mesoderm from human iPSCs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... 2017 Sensory Inc ., a ... for consumer electronics, and i nnerCore ... cybersecurity solutions, today announced a global partnership that ... worldwide to bolster security of data sensitive mobile ... authentication platforms they offer, innerCore now offers its ...
(Date:1/18/2017)... -- In vitro diagnostic (IVD) companies were very active in ... Kalorama Information expects that trend to continue – though ... uncertainty in reimbursement and healthcare reform in ... acquisitions landscape. Instead of looking to buy technology, the ... of their home country and also to increase their ...
(Date:1/18/2017)... Minn. , Jan. 18, 2017 ... technology company that supports the entire spectrum of ... has been another record-breaking year for the organization ... market interest in MedNet,s eClinical products and services. ... the tremendous marketplace success of iMedNet ...
Breaking Biology News(10 mins):
(Date:1/19/2017)... ... January 19, 2017 , ... ... pharmaceutical research and development (R&D), today announced the launch of Data ... interpretation for the rapidly evolving field of precision medicine. , Data ...
(Date:1/19/2017)... , ... January 19, 2017 , ... ... product vigilance software to leading biopharmaceutical and medical device manufacturers and regulators, is ... fully 21 CFR Part 11-compliant email client designed to provide product vigilance departments ...
(Date:1/19/2017)... Md. and GAITHERSBURG, Md. ... (NYSE MKT: PIP) and Altimmune, Inc., a privately-held ... signing of a definitive agreement for the merger ... Altimmune,s current investors include Novartis Venture Fund, HealthCap, ... will be a fully-integrated and diversified immunotherapeutics company ...
(Date:1/19/2017)...  ArmaGen, Inc., today announced that it has ... executive officer, as well as a member of ... more than 17 years of executive management experience ... and pharmaceuticals. "Mathias is a ... skillset necessary to lead ArmaGen to its next ...
Breaking Biology Technology: